Effects of glucagon-like peptide-1 analogues on hard binary outcomes for patients at increased risk of cardiovascular events: a protocol for a systematic review with network meta-analysis and Trial Sequential Analysis.
第一单位:
Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark christina.sillassen@ctu.dk.;Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark.;Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
作者:
医学主题词
人类(Humans);心血管疾病(Cardiovascular Diseases);糖尿病, 2型(Diabetes Mellitus, Type 2);胰高血糖素样肽1(Glucagon-Like Peptide 1);研究设计(Research Design);降血糖药(Hypoglycemic Agents);胰高血糖素样肽类(Glucagon-Like Peptides);Meta分析(主题)(Meta-Analysis as Topic);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1136/bmjopen-2024-098205
PMID
41371743
发布时间
2026-01-06
- 浏览0
BMJ open
e098205页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



